Brief: Voyager Therapeutics Presents Data For Second-Generation, Tracer™-Generated Capsids And Cns Gene Therapy Programs Advancing Toward Clinical Trials At The Asgct 27Th Annual Meeting
08/05/2024 11:34
May 8 (Reuters) - Voyager Therapeutics Inc VYGR.O :
* VOYAGER THERAPEUTICS PRESENTS DATA FOR SECOND-GENERATION,
TRACER™-GENERATED CAPSIDS AND CNS GENE THERAPY PROGRAMS
ADVANCING TOWARD CLINICAL TRIALS AT THE ASGCT 27TH ANNUAL
MEETING
Source text for Eikon: ID:nGNXbLLN4P
Further company coverage: VYGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview